Haemonetics (HAE) Receivables (2010 - 2026)

Haemonetics' Receivables history runs 17 years deep, the most recent figure standing at $5.5 million for Q1 2026.

• On a quarterly basis, Receivables fell 97.29% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 97.29% decrease from a year earlier, with the FY2026 full-year figure at $216.9 million, up 7.01% from the prior year.
• Receivables retreated to $5.5 million in Q1 2026 per HAE's latest filing, from $195.7 million in the prior quarter.
• Across five years, Receivables topped out at $213.5 million in Q3 2024 and bottomed at $5.2 million in Q1 2024.
• The 5-year median for Receivables is $180.1 million (2022), against an average of $166.6 million.
• Across the five-year window, Receivables jumped 3797.25% in 2025 and tumbled 97.29% in 2026, its largest moves.
• Year by year, Receivables stood at $181.1 million in 2022, then gained by 16.85% to $211.6 million in 2023, then rose by 0.16% to $211.9 million in 2024, then decreased by 7.66% to $195.7 million in 2025, then plunged by 97.19% to $5.5 million in 2026.
• Per Business Quant, the three latest HAE Receivables figures stand at $5.5 million (Q1 2026), $195.7 million (Q4 2025), and $207.1 million (Q3 2025).